Alan Au
Fundador en GT Capital Investment Ltd. .
Cargos activos de Alan Au
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
GT Capital Investment Ltd.
GT Capital Investment Ltd. Investment ManagersFinance GT Capital Investment Ltd. is an Independent Private Equity/Venture Capital firm founded in 2013 by Alan Au. GT Capital Investment Ltd. is headquartered in Hong Kong. | Fundador | 01/01/2013 | - |
Inversor de Capital Privado | 01/01/2013 | - | |
Oxford Investment Consultants LLP
Oxford Investment Consultants LLP Investment ManagersFinance Oxford Investment Consultants LLP (Oxford Investment Consultants) is a venture capital firm founded in 2015 by George Edward Silvanus Robinson and Ross Hyett. The firm is headquartered in Oxford, London. | Consultor / Asesor | - | - |
G.I. Windows, Inc.
G.I. Windows, Inc. BiotechnologyHealth Technology G.I. Windows, Inc. develops and markets a technology which involves a series of self assembling magnets (SAMSEN) for incision less bypass procedures within the digestive system. It specializes in non-surgical bypass and nitial clinical applications. The company was founded by Christopher Thompson and Marvin Ryou and is headquartered in West Bridgewater, MA. | Director/Miembro de la Junta | - | - |
Historial de carrera de Alan Au
Antiguos cargos conocidos de Alan Au.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Cellular Biomedicine Group (Shanghai) Ltd.
Cellular Biomedicine Group (Shanghai) Ltd. BiotechnologyHealth Technology Cellular Biomedicine Group (Shanghai) Ltd. engages in development and sales of laboratory equipment and consumables, biological reagents. The company was founded on October 19, 2011 and is headquartered in Shanghai, China. | Director/Miembro de la Junta | 01/11/2014 | 01/02/2021 |
I-MAB Biopharma Co., Ltd.
I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | Director/Miembro de la Junta | 01/12/2019 | - |
Formación de Alan Au.
The Chinese University of Hong Kong | Undergraduate Degree |
Columbia Business School | Masters Business Admin |
Estadísticas
Internacional
Estados Unidos | 3 |
Hong-Kong | 3 |
China | 3 |
Operativa
Director/Board Member | 3 |
Founder | 1 |
Private Equity Investor | 1 |
Sectorial
Health Technology | 4 |
Consumer Services | 3 |
Finance | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 5 |
---|---|
G.I. Windows, Inc.
G.I. Windows, Inc. BiotechnologyHealth Technology G.I. Windows, Inc. develops and markets a technology which involves a series of self assembling magnets (SAMSEN) for incision less bypass procedures within the digestive system. It specializes in non-surgical bypass and nitial clinical applications. The company was founded by Christopher Thompson and Marvin Ryou and is headquartered in West Bridgewater, MA. | Health Technology |
Oxford Investment Consultants LLP
Oxford Investment Consultants LLP Investment ManagersFinance Oxford Investment Consultants LLP (Oxford Investment Consultants) is a venture capital firm founded in 2015 by George Edward Silvanus Robinson and Ross Hyett. The firm is headquartered in Oxford, London. | Finance |
Cellular Biomedicine Group (Shanghai) Ltd.
Cellular Biomedicine Group (Shanghai) Ltd. BiotechnologyHealth Technology Cellular Biomedicine Group (Shanghai) Ltd. engages in development and sales of laboratory equipment and consumables, biological reagents. The company was founded on October 19, 2011 and is headquartered in Shanghai, China. | Health Technology |
GT Capital Investment Ltd.
GT Capital Investment Ltd. Investment ManagersFinance GT Capital Investment Ltd. is an Independent Private Equity/Venture Capital firm founded in 2013 by Alan Au. GT Capital Investment Ltd. is headquartered in Hong Kong. | Finance |
I-MAB Biopharma Co., Ltd.
I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | Health Technology |
- Bolsa de valores
- Insiders
- Alan Au
- Experiencia